Astromech, which uses genomic data to build predictive AI models of biological change, raised $20M at a $3.8B valuation, bringing its total funding to $60M (Dean Takahashi/GamesBeat)

Astromech, a startup that uses genomic data to create predictive AI models of biological change, secured a $20 million financing round, valuing the company at $3.8 billion and bringing its total capital raised to $60 million. The funding will accelerate development of its AI-driven biological prediction platform.